StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)

Close on Nov 17, 2026Market cap –P/E 48.4Yield –

argenx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $685.19M. The highest annual figure on record is $685.19M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$685.19M–
FY2024Dec 31, 2024-$82.75M–
FY2023Dec 31, 2023-$420.33M–
FY2022Dec 31, 2022-$862.81M–
FY2021Dec 31, 2021-$606.81M–
FY2020Dec 31, 2020-$398.46M-362.8%
FY2019Dec 31, 2019$151.63M–

More argenx figures

See a number that looks wrong?